transscript reverse transcriptase (TaKaRa)
99
Structured Review
TaKaRa
transscript reverse transcriptase
Transscript Reverse Transcriptase, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 486 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transscript+kit/PrimeScript+FAST+RT+reagent+Kit+with+gDNA+Eraser/pm41892025-54-22-26
Average 99 stars, based on 486 article reviews
Transscript Reverse Transcriptase, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 486 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transscript+kit/PrimeScript+FAST+RT+reagent+Kit+with+gDNA+Eraser/pm41892025-54-22-26
Average 99 stars, based on 486 article reviews
transscript reverse transcriptase - by Bioz Stars,
2026-11
99/100 stars
Images
Related Articles
Reverse Transcription:Article Title: Analysis of crucial genes, pathways and construction of the molecular regulatory networks in vascular smooth muscle cell calcification Article Snippet: .. Total RNA was reverse-transcribed into complementary (c)DNA using the Article Title: AtPQT11, a P450 enzyme, detoxifies paraquat via N-demethylation Article Snippet: .. We extracted the RNA from one-week-old seedlings by Trizol (Invitrogen, Carlsbad, California, USA) and reverse transcribed RNA to cDNA by Synthesized:Article Title: LncRNA MALAT1 Suppression Protects Endothelium against oxLDL-Induced Inflammation via Inhibiting Expression of MiR-181b Target Gene TOX Article Snippet: .. The first cDNA strand was synthesized using approximately 2 μ g RNA with the Article Title: Inhibition of miR-29b suppresses MAPK signaling pathway through targeting SPRY1 in atherosclerosis. Article Snippet: The treatment of atherosclerosis (AS), a severe condition associated with the pathogenesis of cardiovascular diseases (CVDs), is still not satisfactory worldwide.. In this study, we aim to investigate whether protein sprout homologue 1 (SPRY1), a upstream mediator of MAPK signal pathway, is the target of miR-29b in vascular endothelium during the development of AS.. ApoE mice model was established, and an inverse correlation was noticed between level of miR-29b and SPRY1 expression in the aortic tissues. |